4D Molecular Therapeutics, Inc. Liquidation Value
FDMT
Other
Cash & Equivalents
$60.24M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $60.24M
Total Obligations: -$65.40M
$-5.16M
Per share: $-0.09
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $60.24M
AR: $0
Total Obligations: -$65.40M
$-5.16M
Per share: $-0.09
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $60.24M
AR: $0
Inventory: $0
Total Obligations: -$65.40M
$-5.16M
Per share: $-0.09
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-5.16M | $-0.09 |
| Liquid Liquidation Value | $-5.16M | $-0.09 |
| Operating Liquidation Value | $-5.16M | $-0.09 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $60.24M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $43.98M |
| Long-term Debt | N/A |
| Op. Lease Liability | $21.41M |
| Finance Lease | N/A |
| Shares Outstanding | 57.6M |
Explore all 163 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $60.24M | N/A | N/A | $11.16M | $43.98M | N/A | $21.41M | N/A |
| 2025-09-30 | $48.55M | N/A | N/A | $6.86M | $37.11M | N/A | $22.26M | N/A |
| 2025-06-30 | $77.16M | N/A | N/A | $8.70M | $34.68M | N/A | $23.08M | N/A |
| 2025-03-31 | $133.53M | N/A | N/A | $4.15M | $26.90M | N/A | $23.85M | N/A |
| 2024-12-31 | $149.34M | N/A | N/A | $4.39M | $29.15M | N/A | $24.61M | N/A |
| 2024-09-30 | $187.54M | N/A | N/A | $2.92M | $29.46M | N/A | $24.83M | N/A |
| 2024-06-30 | $189.06M | N/A | N/A | $3.43M | $19.40M | N/A | $13.66M | N/A |
| 2024-03-31 | $275.59M | N/A | N/A | $4.22M | $16.40M | N/A | $14.17M | N/A |
▼ Community Notes